welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Quest Diagnostics Launches Three Genetic Test Panels for Predicting Hereditary Cancer Risk
Quest Diagnostics launches three new test panels under its Quest Vantage brand. The lab-developed panels employ next-generation sequencing and a proprietary bioinformatics platform to identify genetic mutations associated with inherited risk of 15 cancers. According to the company, ~170K diagnoses are made in the U.S. each year of cancers that result from inherited genetic mutations. The tests only include genes that meet certain criteria such as a 2x increase in cancer risk, an association with a disease syndrome where cancer may occur and guideline support for genetic counseling. Quest will showcase the new panels at ASCO in Chicago.
expertly curated content related to this topic
- Colonoscopy Prep: TipsAhhh, colon prep! When I had a colon, th...
- Attitudes Toward Genetic Testing in Childhood and Reproductive Decision-Making for Familial Adenomatous PolyposisChildhood DNA testing, prenatal diagnosi...
- Inherited Risk For Colorectal CancerFamilial adenomatous polyposis (FAP) is ...
- Genomic Era Diagnosis and Management of Hereditary and Sporadic Colon CancerThe morbidity and mortality attributable...
- Medline Plus Overview on Colorectal Polyps: Causes, Symptoms, and ManagementA colorectal polyp is a growth on the li...
- Lynch Syndrome and MYH-Associated Polyposis: Review and Testing StrategyIndividuals with Lynch syndrome have an ...
English
Portuguese
Spanish